The transfer of a pharmacy involves several branches of law, taxation, and urban planning. Before even considering the new location, the legal form of the transfer and capital constraints determine the feasibility of the project. Understanding the steps of transferring a pharmacy requires going beyond simple administrative chronology to incorporate parameters often underestimated by candidates for relocating a pharmacy.
Form of the transfer: sale of assets, sale of shares, or gradual takeover
Classic guides present the transfer as a physical move accompanied by an ARS file. The legal reality is more fragmented. A buyer can acquire the business as a whole, buy the shares of the operating SEL, or take control of the capital gradually over several months.
Each option produces distinct effects on the liabilities assumed, the applicable taxation, and the overall timeline of the operation. A sale of shares, for example, transfers all debts and commitments of the company, whereas a sale of assets allows for the selection of the elements being transferred. The choice between these paths also conditions the setup of bank financing and the negotiation of the price.
The chosen form of transfer weighs as heavily as the choice of location on the viability of the project. An assistant pharmacist considering becoming the owner through a gradual buyout of shares will not have the same constraints as an owner selling their business to relocate elsewhere.
SPFPL ownership ceiling and consolidation strategy
Ordinance No. 2023-77 of February 8, 2023, which comes into effect on September 1, 2024, has modified the rules applicable to financial participation companies for liberal professions (SPFPL) in pharmacy. An SPFPL of retail pharmacists can only hold shares in a maximum of three retail SELs. This limit, set by Article R. 5125-18 of the Public Health Code, directly frames external growth strategies.
For a pharmacist considering a transfer coupled with a consolidation of licenses, this ceiling necessitates making choices. If the holding already owns shares in three SELs, any new acquisition requires selling an existing share or restructuring the setup. Field feedback varies on the actual flexibility of this limit: some legal advisors believe it hampers consolidations in rural areas, while others argue it protects the pharmacy network.
ARS file and review period: what the Public Health Code says
The request for transfer authorization is sent to the director general of the territorially competent ARS. The file must include several mandatory elements:
- The identity and qualifications of each pharmacist owner or partner of the operating company
- The current location of the pharmacy and the projected address of the new premises, accompanied by proof of rights to the premises
- Elements to verify compliance with demographic conditions (served population, distance from neighboring pharmacies)
- If applicable, documents related to the consolidation of licenses if the transfer is accompanied by an absorption
The review period begins from the acknowledgment of completeness of the file, not from the date of submission. An incomplete file suspends the countdown. Article R. 5125-18-1 of the Public Health Code governs this procedure, and the administration’s silence regime operates here in a specific manner: the absence of a response within the allotted time does not imply automatic acceptance in all cases.
Priority and competition between requests
When several pharmacists submit a transfer request to the same geographical area, a priority system applies. The priority of submission of a complete file takes precedence over subsequent requests. This rule makes advance preparation crucial: a file completed in a few weeks will prevail over a more ambitious project submitted late.
Financing the transfer and valuation of the license
The price of a pharmacy includes the value of the business (clientele, brand, lease rights) and that of the stock. The operating license, however, has no standalone market value under French law: it is attached to the business and cannot be sold separately. However, the location of the new premises directly influences the post-transfer valuation.
Bank financing for a transfer differs from that of a simple acquisition. Lenders assess the risk associated with the change of location: potential loss of clientele, cost of renovations for the new premises, duration of the transition period. An assistant pharmacist without significant equity will often need to present a strengthened forecast to convince the credit committee.
Role of the Order and additional formalities
Registration with the Order of Pharmacists must be updated to reflect the change of practice address. This formality, distinct from the ARS authorization, conditions the legality of operations at the new site. The documents to be provided to the Order concern the legal status of the company, the identity of the partners, and the compliance of the premises with applicable safety standards for establishments receiving the public.
The transfer of a pharmacy remains an operation where the legal and capital dimension weighs as heavily as the ARS administrative aspect. The SPFPL ownership ceiling, the choice between sale of assets and sale of shares, the priority rule for files: these parameters, rarely addressed together, nonetheless determine the success or failure of the project long before the new curtain rises.
